Prevalence and clinical correlates ofJAK2mutations in Down syndrome acute lymphoblastic leukaemia-Reference-Cited by-同舟云学术

Prevalence and clinical correlates ofJAK2mutations in Down syndrome acute lymphoblastic leukaemia

Published:2009-03 Issue:6 Volume:144 Page:930-932
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Gaikwad Amos,Rye Cassia L.,Devidas Meenakshi,Heerema Nyla A.,Carroll Andrew J.,Izraeli Shai,Plon Sharon E.,Basso Giuseppe,Pession Andrea,Rabin Karen R.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07552.x/fullpdf

Reference6 articles.

1. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down’s syndrome;Bercovich;Lancet,2008

2. Risks of leukaemia and solid tumours in individuals with Down’s syndrome;Hasle;Lancet,2000

3. A specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukaemia;Kearney;Blood,2008

4. Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia;Malinge;Blood,2007

5. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples;Peto;British Journal of Cancer,1977

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14

2. Down syndrome and leukemia: An insight into the disease biology and current treatment options;Blood Reviews;2023-11

3. Hematologic Neoplasms Associated with Down Syndrome: Cellular and Molecular Heterogeneity of the Diseases;International Journal of Molecular Sciences;2023-10-18

4. Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer;Pharmacological Reviews;2022-12-08

5. JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies;Frontiers in Cell and Developmental Biology;2022-07-12